Managers

OrbiMed leads Series C round for Synthorx

La Jolla, California-based Synthorx Inc, a developer of novel protein therapeutics, has raised $63 million in Series C financing. OrbiMed led the round with participation from Medicxi, Osage University Partners, Avalon Ventures, RA Capital Management and Correlation Ventures. In addition to the funding, Dr. Peter Thompson and Vickie Capps will join the Synthorx board of directors.

NovellusDx snags $6 mln

Jerusalem-based NovellusDx, a provider of functional genomics, has raised $6 million in funding. The investors were Helsinn Group, Bio Capital Impact Fund and Windham Venture Partners.

Crescendo Biologics rakes in $70 mln Series B

UK-based Crescendo Biologics Ltd, a biopharmaceutical company, has closed $70 million in Series B financing. Andera Partners led the round with participation from other investors that included Quan Capital.

The Hive raises $26.5 mln third fund from Verizon Ventures, Software AG, GE, Rockwell Automation, March Capital, others

The Hive said it raised a $26.5 million third fund from investors including Verizon Ventures, Software AG, General Electric, Rockwell Automation, March Capital Partners and unnamed individuals.

Columbus, Ohio, flourishes as a startup ecosystem, but Buckeye State IPOs remain elusive

Sequoia China, cryptocurrency exchange Binance face off in deal-talks dispute

Trust Ventures targets $50 mln for inaugural fund

Trust Ventures is seeking to raise $50 million for its initial fund, according to an SEC filing. Based in Austin, Trust Ventures invests in startups that focus on challenging government regulations.

Pinnacle Ventures to raise fifth venture capital fund

Pinnacle Ventures has set out to raise a fifth venture capital fund, according to a filing with the SEC.

NEA, Insight, Oak top newly minted venture portfolio at LA pension

Student pressure to divest from fossil fuels may affect PE at Swarthmore